K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.

Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion.

Human papillomavirus infection as a prognostic marker for lung adenocarcinoma: a systematic review and meta-analysis.

Advances in EGFR as a Predictive Marker in Lung Adenocarcinoma.

KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer.

Fibulin-1 functions as a prognostic factor in lung adenocarcinoma.

KRAS mutation as a prognostic factor in ampullary adenocarcinoma: a meta-analysis and review.

Analytical validation of a proliferation-based molecular signature used as a prognostic marker in early stage lung adenocarcinoma.

Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.

c-erbB-2 oncogene as a prognostic marker in breast cancer.

Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma.

DNA methylation profiling identifies the HOXA11 gene as an early diagnostic and prognostic molecular marker in human lung adenocarcinoma.

Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma.

Lin28B is a novel prognostic marker in gastric adenocarcinoma.

Targeting pathways downstream of KRAS in lung adenocarcinoma.

The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.

A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients.

Druggable oncogene fusions in invasive mucinous lung adenocarcinoma.

The COPD Assessment Test as a Prognostic Marker in Interstitial Lung Disease.

Enteric-type adenocarcinoma of the lung harbouring a novel KRAS Q22K mutation with concomitant KRAS polysomy: a case report.

CHKA mediates the poor prognosis of lung adenocarcinoma and acts as a prognostic indicator.

KRAS mutation in lung metastases from colorectal cancer: prognostic implications.

Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer.

Thymidine kinase 1 is a better prognostic marker than Ki-67 for pT1 adenocarcinoma of the lung.

Identification of adipophilin as a potential diagnostic tumor marker for lung adenocarcinoma.

Suggest Documents

Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion.

Human papillomavirus infection as a prognostic marker for lung adenocarcinoma: a systematic review and meta-analysis.

Advances in EGFR as a Predictive Marker in Lung Adenocarcinoma.

KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer.

Fibulin-1 functions as a prognostic factor in lung adenocarcinoma.

KRAS mutation as a prognostic factor in ampullary adenocarcinoma: a meta-analysis and review.

Analytical validation of a proliferation-based molecular signature used as a prognostic marker in early stage lung adenocarcinoma.

Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.

c-erbB-2 oncogene as a prognostic marker in breast cancer.

Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma.

DNA methylation profiling identifies the HOXA11 gene as an early diagnostic and prognostic molecular marker in human lung adenocarcinoma.

Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma.

Lin28B is a novel prognostic marker in gastric adenocarcinoma.

Targeting pathways downstream of KRAS in lung adenocarcinoma.

The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.

A Pilot Study Evaluating Serum MMP7 as a Preoperative Prognostic Marker for Pancreatic Ductal Adenocarcinoma Patients.

Druggable oncogene fusions in invasive mucinous lung adenocarcinoma.

The COPD Assessment Test as a Prognostic Marker in Interstitial Lung Disease.

Enteric-type adenocarcinoma of the lung harbouring a novel KRAS Q22K mutation with concomitant KRAS polysomy: a case report.

CHKA mediates the poor prognosis of lung adenocarcinoma and acts as a prognostic indicator.

KRAS mutation in lung metastases from colorectal cancer: prognostic implications.

Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer.

Thymidine kinase 1 is a better prognostic marker than Ki-67 for pT1 adenocarcinoma of the lung.

Identification of adipophilin as a potential diagnostic tumor marker for lung adenocarcinoma.

K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung.

Recommend Documents

Follow Us